Venus Remedies Limited Bortezomib Export Data — India (DGFT 2022–2026)

Name: Venus Remedies Limited Bortezomib Export Records India — #4 Exporter, 44 Shipments, $864.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Bortezomib

India Pharmaceutical Trade Intelligence

$21.9M200 Suppliers109 CountriesHS 30049049

ExportsIndia → BRAZIL28.3%India → UNITED STATES25.4%

ImportsITALY → India$200.0K UNITED STATES → India$72.1K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: EUGIA US

Venus Remedies Limited — Bortezomib Exporter #4 | $864.3K Trade Value | TransData Nexus | TransData Nexus

Venus Remedies Limited — Bortezomib Exporter Profile

Indian Pharmaceutical Exporter · #4 for Bortezomib · $864.3K export value · DGFT Verified

Venus Remedies Limited is the #4 Indian exporter of Bortezomib with $864.3K in export value and 44 verified shipments. Venus Remedies Limited holds a 4.0% market share in Bortezomib exports across 16 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.

Venus Remedies Limited — Bortezomib Export Profile: Buyers & Destinations

Venus Remedies Limited Bortezomib export treemap — buyers and destination countries | TransData Nexus

Where Does Venus Remedies Limited Export Bortezomib?

Country	Value	Shipments	Share
DOMINICAN REPULIC	$202.9K	5	25.8%
DOMINICAN REPUBLIC	$118.8K	3	15.1%
MOROCCO	$113.0K	8	14.4%
GERMANY	$84.1K	3	10.7%
HUNGARY	$67.8K	2

Who Are the Top Buyers of Bortezomib from Venus Remedies Limited?

Buyer	Country	Value	Orders
P T	DOMINICAN REPUBLIC	$159.2K	4
V P G	GERMANY	$84.1K	3
PHARMACEUTICAL TECHNOLOGY	DOMINICAN REPULIC	$80.8K	2
P P	MOROCCO	$76.9K	6
E P H K	HUNGARY	$67.8K	2
TO THE ORDER OF:	VIETNAM, DEMOCRATIC REP. OF	$42.9K	1
M/S PHARMACEUTICAL TECHNOLOGY	DOMINICAN REPULIC	$41.6K	1
P T M S PHARMACEUTICAL TECHNOLOGYCALLE DESIDERIO VALVERDE	DOMINICAN REPUBLIC	$40.1K	1
ROUTE DEL JADIDA	MOROCCO	$36.1K	2
PT M L	INDONESIA	$29.9K	1

Venus Remedies Limited supplies Bortezomib to 24 buyers globally. The largest buyer is P T (DOMINICAN REPUBLIC), followed by V P G (GERMANY) and PHARMACEUTICAL TECHNOLOGY (DOMINICAN REPULIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Bortezomib Formulations Does Venus Remedies Limited Export?

Product Description / Formulation	Value	Shipments
CYTOMIB 3.5 MG (BORTEZOMIB LYOPHILIZED P	$72.3K	3
BORTEZOMIB POWDER FOR SOLUTION FOR INJ.3.5 MG BORTEZOMIB BIOTEACH PHARMA 3.5MG	$50.0K	1
BORTEZOMIB POWDER FOR SOLUTION FOR INJECTION 3.5 MG BORTEZOMIB BIOTEACH PHARMA LIMITED 3.5MG	$50.0K	1
VOTOBEL BORTEZOMIB 3 5 MG LYOPHILIZED POWDER FOR INJECTABLE SOLUTION VOTOBEL 3 5 MG B N X3AG022A MD 01 2023 ED 12 2024	$41.8K	1
BORTEZOMIB 3.5 MG LYOPHILIZED POWDER FORINJECTABLE SOL.VOTOBEL 3.5 MG.BN.X4DBO012A MFG. DT.04/2024 EXP.DT. 03/2026	$41.6K	1
VOTOBEL ( BORTEZOMIB 3.5 MG LYOPHILIZED	$41.6K	1
VOTOBEL BORTEZOMIB 3.5 MG LYOPHILIZED POWDER FOR INJECTABLE SOLUTION	$40.1K	1
BORTEZOMIB 3.5 MG LYOPHILIZED POWDER FORINJCTABLE SOLUTION (VOTOBEL 3.5 MG) B.N.X5CBO042B MD.03/2025 ED.02/2027	$39.6K	1
VOTOBEL 3.5 MG BORTEZOMIB 3.5 MG LYOPHILIZED POWDER FOR INJECTABLE SOLUTION EACHVIAL CONTAINS: BORTEZOMIB ...3.5 MG	$39.1K	1
VOTOBEL (BORTEZOMIB 3.5 MG LYOPHILIZED P	$39.0K	1

Venus Remedies Limited exports 41 distinct Bortezomib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CYTOMIB 3.5 MG (BORTEZOMIB LYOPHILIZED P with 3 shipments worth $72.3K.

How Does Venus Remedies Limited Compare to Nearest Bortezomib Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	EUGIA PHARMA SPECIALITIES LIMITED	$3.5M	69	10	$50.0K
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$2.9M	57	5	$50.0K
4	VENUS REMEDIES LIMITED ★	$864.3K	44	16	$19.6K
5	FRESENIUS KABI ONCOLOGY LIMITED	$803.7K	99	10	$8.1K
6	DR REDDYS LABORATORIES LIMITED	$500.0K	10	6	$50.0K

Venus Remedies Limited ranks #4 among 200 Indian Bortezomib exporters. Average shipment value of $19.6K compared to the market average of $68.4K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Bortezomib Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	263	19.0%
SAHAR AIR	229	16.6%
DELHI AIR CARGO ACC (INDEL4)	168	12.1%
DELHI AIR	148	10.7%
HYDERABAD ACC (INHYD4)	82	5.9%
HYDERABAD AIR	82	5.9%
Bombay Air	62	4.5%
Bombay Air Cargo	32	2.3%

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Bortezomib Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)

Venus Remedies Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)

These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Bortezomib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 44 individual customs records matching Venus Remedies Limited exporting Bortezomib, covering 41 formulations to 17 countries via 24 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 498+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Bortezomib

Bortezomib

Venus Remedies Limited — Bortezomib Exporter Profile

Venus Remedies Limited — Bortezomib Export Profile: Buyers & Destinations

Where Does Venus Remedies Limited Export Bortezomib?

Who Are the Top Buyers of Bortezomib from Venus Remedies Limited?

What Is India's Total Bortezomib Export Value and How Much Does Venus Remedies Limited Contribute?

What Is the Average Shipment Value for Venus Remedies Limited's Bortezomib Exports?

How Does Venus Remedies Limited Compare to Other Indian Bortezomib Exporters?

What Bortezomib Formulations Does Venus Remedies Limited Export?

How Does Venus Remedies Limited Compare to Nearest Bortezomib Exporters?

Which Indian Ports Ship Bortezomib Exports?

What Other Advanced Oncology Products Does Venus Remedies Limited Export?

Bortezomib — Export Intelligence Video

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Bortezomib Exports

Venus Remedies Limited — Regulatory Compliance & Quality Standards

About Venus Remedies Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Bortezomib Export Data from Venus Remedies Limited

Bortezomib Stats

Company Overview

Top Products by Venus Remedies Limited

Related Analysis

Need Detailed Export Data?

Data Source